Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Salvador Martin Algarra"'
Autor:
Karmele Mujika, Pablo Luna, Victoria Eugenia Castellón Rubio, Javier Pérez Altozano, María José Lecumberri Biurrun, Jose Luis Manzano, María Eugenia Ortega, Virtudes Soriano, José Antonio López Martín, Delvys Rodriguez-Abreu, Luis Antonio Fernandez-Morales, Salvador Martin Algarra, Jordi Rubió-Casadevall, Anabel Ballesteros, Almudena Garcia, Ivan Marquez-Rodas, Teresa Puértolas Hernández, María Rodríguez de la Borbolla Artacho, Ainara Soria, Enrique Espinosa Arranz, Javier Martínez, Alfonso Berrocal, José Miguel Jurado García, Isabel Palacio, Ovidio Fernández, Miguel-Ángel Berciano-Guerrero, Ana Arance
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Consejería de Sanidad de la Comunidad de Madrid
Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with metastatic melanoma.This retrospective, observational study involved 135 patients with unre
Autor:
José Manuel Aramendía, Jose Manuel Ordoñez, Javier Aristu, Salvador Martin Algarra, Rafael Martínez Monje, Esteban Salgado, Maria Gonzalez Cao, Antonio Brugarolas
Publikováno v:
American Journal of Clinical Oncology. 25:480-484
The purpose of this study was to evaluate the efficacy and tolerance of combined irinotecan and vinorelbine in previously treated patients with stage IIIB and IV non-small-cell lung cancer (NSCLC). Thirty-three patients with NSCLC (7 stage IIIB and 2
Autor:
Antonio Brugarolas, C. Beltran, José Javier Aristu, M. Moreno, Salvador Martin Algarra, Joseba Rebollo, Ignacio Azinovic, Rafael Martínez-Monge, José María López-Picazo, Oscar A Fernández, José Manuel Aramendía
Publikováno v:
American Journal of Clinical Oncology. 25:347-353
Multidisciplinary treatment in high-risk breast cancer improves survival and local control. The feasibility and patterns of failure after several induction and high-dose consolidation regimens of chemotherapy were evaluated in this study. Between Nov
Autor:
Lorenzo Alonso, Enrique Espinosa, Alfonso Berrocal, Ana Arance, Javier Valdivia, Eva Muñoz, Salvador Martin Algarra, Virtudes Soriano, Pilar Lopez Criado, José Antonio López Martín
Publikováno v:
Melanoma Research
Ipilimumab, a fully human, recombinant, monoclonal antibody to cytotoxic T-lymphocyte antigen 4 improves overall survival (OS) in previously treated and untreated metastatic melanoma. This retrospective analysis reports data gathered by a questionnai
Autor:
Mariano Provencio Pulla, Joan Manel Gasent Blesa, Salvador Martin Algarra, Emilio González, Vicente Alberola Candel
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 11(1)
Platinum resistant ovarian cancer is a current challenge in Oncology. Current approved therapies offer no more of a 20% of response. New therapeutic options are urgently needed. Patients were treated with the combination of Pemetrexed 500 mg/m2 d1 an